株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

在宅点滴療法市場予測 2013-2024年:製品別 (注入ポンプ、静注セット、静注カニューレ、ニードレスコネクター)、用途別、およびセグメント別分析

Home Infusion Therapy Market Analysis By Product (Infusion Pumps, IV Sets, IV Cannulas, Needleless Connectors), By Application (Anti-Infectives, Endocrinology, Hydration Therapy, Parenteral Nutrition), And Segment Forecasts, 2013 - 2024

発行 Grand View Research, Inc. 商品コード 342348
出版日 ページ情報 英文 100 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=114.58円で換算しております。
Back to Top
在宅点滴療法市場予測 2013-2024年:製品別 (注入ポンプ、静注セット、静注カニューレ、ニードレスコネクター)、用途別、およびセグメント別分析 Home Infusion Therapy Market Analysis By Product (Infusion Pumps, IV Sets, IV Cannulas, Needleless Connectors), By Application (Anti-Infectives, Endocrinology, Hydration Therapy, Parenteral Nutrition), And Segment Forecasts, 2013 - 2024
出版日: 2016年12月23日 ページ情報: 英文 100 Pages
概要

世界の在宅点滴療法市場は2024年までに283億米ドルに達すると予測されています。医療費の急上昇によって、長期ケアを必要とする患者の間で、在宅点滴療法を選択する率が高まっています。

当レポートでは、世界の在宅点滴療法市場について分析し、製品別、用途別見通しとともに、地域別動向などをまとめています。

第1章 調査方法と調査範囲

第2章 エグゼクティブサマリー

第3章 在宅点滴療法業界見通し

  • 市場セグメンテーション
  • 市場規模と成長見通し
  • 市場動向
    • 促進因子
    • 阻害因子
  • 優先される主な機会
  • 業界分析:ポーターズ
  • PESTEL分析

第4章 製品見通し

  • 製品別市場シェア
  • 注入ポンプ
  • 静注セット
  • 静注カニューレ
  • ニードレスコネクター

第5章 用途別見通し

  • 用途別市場シェア
  • 抗炎症
  • 分泌学
  • 水和療法
  • 化学療法
  • 経腸栄養
  • 非経口栄養
  • 特殊医薬品
  • その他

第6章 地域別見通し

  • 地域別市場シェア
  • 北米
  • 欧州
  • アジア太平洋地域
  • ラテンアメリカ
  • 中東・アフリカ

第7章 競合環境

  • B. Braun Melsungen
  • Baxter Inc
  • Caesarea Medical Electronics
  • CareFusion Corporation
  • Fresenius Kabi
  • ICU Medical Inc.
  • JMS Co. Ltd.
  • Smiths Medical
  • テルモ株式会社

図表

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: 978-1-68038-389-8

The global home infusion therapy market is expected to be USD 28.3 billion by 2024, based on a new report by Grand View Research, Inc. Increasing need to contain the soaring healthcare costs has led to a higher preference for home infusion therapies amongst patients requiring long-term care.

The growing healthcare expenditure level is a key concern amongst patients and governments worldwide, necessitating the implementation of effective measures to curb these costs. Hence, the home healthcare option serves as a cost-effective alternative to expensive hospital stays, which is expected to serve this market as a high impact rendering driver throughout the forecast period. Moreover, increasing awareness about the high prevalence of hospital-acquired infections is anticipated to accentuate the importance of home healthcare.

Currently, the major chronic diseases, such as cancer, diabetes, respiratory disorders, cardiovascular diseases, and other life threatening diseases, account for 60% of the total death count and 43% of the global disease burden. The administration of medication in the home setting provides several advantages to patients, which include faster recovery, greater comfort, fewer complications, cost savings, and others. This is expected to drive the growth of the market in the near future.

Further Key Findings From The Study Suggest:

  • The product segment was dominated by infusion pumps with a market share of around 45.0% in 2015 owing to the greater number of initiatives conducted by the key players pertaining to new product development.
  • Needleless connectors are projected to witness the highest CAGR over the forecast period owing to greater benefits associated with their use in comparison to needle connectors.
  • Anti-infectives segment contributed to the largest market revenue in 2015. This is mainly due to the fact that it is frequently employed for patients in homecare settings.
  • Chemotherapy segment is anticipated to exhibit the highest CAGR of over 9.0% over the forecast period, which is attributable to technological advancements that render their usage convenient.
  • Use of injectable drug therapy in endocrinology is also estimated to gain lucrative growth over the forecast period owing to increasing awareness levels of insulin pumps among patients and healthcare providers.
  • North America dominated the market in 2015 with revenue of around USD 5.0 billion. Rising government programs and initiatives to promote awareness pertaining to the benefits of home infusion therapy have resulted in the higher revenue generation in this region
  • Strategic collaborations, regional expansion efforts, and mergers and acquisitions are some of the foremost strategies adopted by the key players. For instance, in January 2014, Terumo Corporation signed an eight-year agreement to collaboratively market, distribute, and co-brand their peripheral I.V. catheter series with CareFusion Corporation.

Table of Contents

Chapter 1: Research Methodology & Scope

  • 1.1. Information procurement
    • 1.1.1. Purchased database:
    • 1.1.2. GVR's Internal Database
  • 1.2. Research Methodology
  • 1.3. Geographic Scope & Assumptions
  • 1.4. Region Wise Market Calculation
    • 1.4.1. Region Wise Market: Base Estimates
    • 1.4.2. Global Market: CAGR Calculation
  • 1.5. Region-based segment share calculation
  • 1.6. List of Secondary Sources

Chapter 2: Executive Summary

  • 2.1. Market Snapshot

Chapter 3: Home Infusion Therapy Industry Outlook

  • 3.1. Market Segmentation
  • 3.2. Market size and growth prospects
  • 3.3. Home infusion therapy Market Dynamics
    • 3.3.1. Market driver analysis
      • 3.3.1.1. Growing geriatric population base
      • 3.3.1.2. Rising prevalence of chronic disorders
      • 3.3.1.3. Rapid technological advancements
      • 3.3.1.4. Growing incidence of hospital acquired infections
      • 3.3.1.5. Home healthcare as cost effective alternative
    • 3.3.2. Market restraint analysis
      • 3.3.2.1. Presence of complicated reimbursement framework and reimbursement cuts
  • 3.4. Key Opportunities Prioritized
  • 3.5. Industry Analysis Porter's
  • 3.6. Home Infusion Therapy PESTEL Analysis

Chapter 4: Home Infusion Therapy Market: Product Estimates & Trend Analysis

  • 4.1. Home infusion therapy market share by product, 2015& 2024
  • 4.2. Infusion pumps
    • 4.2.1. Infusion pumps market, 2013-2024(USD Million)
  • 4.3. Intravenous Sets
    • 4.3.1. Intravenous sets market, 2013-2024(USD Million)
  • 4.4. IV cannulas
    • 4.4.1. IV cannulas market, 2013-2024(USD Million)
  • 4.5. Needleless connectors
    • 4.5.1. Needleless connectors market, 2013-2024(USD Million)

Chapter 5: Home Infusion Therapy Market: Application Estimates & Trend Analysis

  • 5.1. Home infusion therapy market share by application, 2015 & 2024
  • 5.2. Anti-Infective
    • 5.2.1. Anti-Infective market, 2013-2024(USD Million)
  • 5.3. Endocrinology
    • 5.3.1. Endocrinology market, 2013-2024(USD Million)
  • 5.4. Hydration Therapy
    • 5.4.1. Hydration therapy market, 2013-2024(USD Million)
  • 5.5. Chemotherapy
    • 5.5.1. Chemotherapy market, 2013-2024(USD Million)
  • 5.6. Enteral Nutrition
    • 5.6.1. Enteral nutrition market, 2013-2024(USD Million)
  • 5.7. Parenteral Nutrition
    • 5.7.1. Parenteral nutrition market, 2013-2024(USD Million)
  • 5.8. Specialty Pharmaceuticals
    • 5.8.1. Specialty pharmaceuticals market, 2013-2024(USD Million)
  • 5.9. Others
    • 5.9.1. Others market, 2013-2024(USD Million)

Chapter 6: Home Infusion Therapy Market: Regional Outlook

  • 6.1. Home infusion therapy market share, by region, 2015 & 2024
  • 6.2. North America
    • 6.2.1. North America home infusion therapy market estimates and forecasts, 2013-2024
    • 6.2.2. U.S.
    • 6.2.3. U.S. home infusion therapy market estimates and forecasts, 2013-2024
    • 6.2.4. Canada
    • 6.2.5. Canada home infusion therapy market estimates and forecasts, 2013-2024
  • 6.3. Europe
    • 6.3.1. Europe home infusion therapy market estimates and forecasts, 2013-2024
    • 6.3.2. Germany
    • 6.3.3. Germany home infusion therapy market estimates and forecasts, 2013-2024
    • 6.3.4. UK
    • 6.3.5. UK home infusion therapy market estimates and forecasts, 2013-2024
  • 6.4. Asia Pacific
    • 6.4.1. Asia Pacific home infusion therapy market estimates and forecasts2013-2024
    • 6.4.2. Japan
    • 6.4.3. Japan home infusion therapy market estimates and forecasts, 2013-2024
    • 6.4.4. China
    • 6.4.5. China home infusion therapy market estimates and forecasts, 2013-2024
  • 6.5. Latin America
    • 6.5.1. Latin America home infusion therapy market estimates and forecasts, 2013-2024
    • 6.5.2. Brazil
    • 6.5.3. Brazil home infusion therapy market estimates and forecasts, 2013-2024
    • 6.5.4. Mexico
    • 6.5.5. Mexico home infusion therapy market estimates and forecasts, 2013-2024
  • 6.6. Middle East and Africa
    • 6.6.1. Middle East and Africa home infusion therapy market estimates and forecasts, 2013-2024(USD Million)
    • 6.6.2. South Africa
    • 6.6.3. South Africa home infusion therapy market estimates and forecasts, 2013-2024

Chapter 7: Competitive Landscape

  • 7.1. B. Braun Melsungen AG
    • 7.1.1. Company Overview
    • 7.1.2. Financial Performance
    • 7.1.3. Product Benchmarking
    • 7.1.4. Strategic Initiatives
  • 7.2. Baxter Inc.
    • 7.2.1. Company Overview
    • 7.2.2. Financial Performance
    • 7.2.3. Product Benchmarking
    • 7.2.4. Strategic Initiatives
  • 7.3. Caesarea Medical Electronics
    • 7.3.1. Company Overview
    • 7.3.2. Financial Performance
    • 7.3.3. Product Benchmarking
    • 7.3.4. Strategic Initiatives
  • 7.4. CareFusion Corporation
    • 7.4.1. Company Overview
    • 7.4.2. Financial Performance
    • 7.4.3. Product Benchmarking
    • 7.4.4. Strategic Initiatives
  • 7.5. Fresenius Kabi
    • 7.5.1. Company Overview
    • 7.5.2. Financial Performance
    • 7.5.3. Product Benchmarking
    • 7.5.4. Strategic Initiatives
  • 7.6. ICU Medical Inc.
    • 7.6.1. Company Overview
    • 7.6.2. Financial Performance
    • 7.6.3. Product Benchmarking
    • 7.6.4. Strategic Initiatives
  • 7.7. JMS Co. Ltd.
    • 7.7.1. Company Overview
    • 7.7.2. Financial Performance
    • 7.7.3. Product Benchmarking
    • 7.7.4. Strategic Initiatives
  • 7.8. Smiths Medical
    • 7.8.1. Company Overview
    • 7.8.2. Financial Performance
    • 7.8.3. Product Benchmarking
    • 7.8.4. Strategic Initiatives
  • 7.9. Terumo Corporation
    • 7.9.1. Company Overview
    • 7.9.2. Financial Performance
    • 7.9.3. Product Benchmarking
    • 7.9.4. Strategic Initiatives

List of Tables

  • TABLE 1: Country share estimation
  • TABLE 2: Home Infusion Therapy - Key market driver analysis
  • TABLE 3: Home Infusion Therapy - Key market restraint analysis
  • TABLE 4: North America home infusion therapy market, by product, 2013 - 2024 (USD Million)
  • TABLE 5: North America home infusion therapy market, by application, 2013 - 2024 (USD Million)
  • TABLE 6: U.S. home infusion therapy market, by product, 2013 - 2024 (USD Million)
  • TABLE 7: U.S. home infusion therapy market, by application, 2013 - 2024 (USD Million)
  • TABLE 8: Canada home infusion therapy market, by product, 2013 - 2024 (USD Million)
  • TABLE 9: Canada home infusion therapy market, by application, 2013 - 2024 (USD Million)
  • TABLE 10: Europe home infusion therapy market, by product, 2013 - 2024 (USD Million)
  • TABLE 11: Europe home infusion therapy market, by application, 2013 - 2024 (USD Million)
  • TABLE 12: Germany home infusion therapy market, by product, 2013 - 2024 (USD Million)
  • TABLE 13: Germany home infusion therapy market, by application, 2013 - 2024 (USD Million)
  • TABLE 14: UK home infusion therapy market, by product, 2013 - 2024 (USD Million)
  • TABLE 15: UK home infusion therapy market, by application, 2013 - 2024 (USD Million)
  • TABLE 16: Asia Pacific home infusion therapy market, by product, 2013 - 2024 (USD Million)
  • TABLE 17: Asia Pacific home infusion therapy market, by application, 2013 - 2024 (USD Million)
  • TABLE 18: Japan home infusion therapy market, by product, 2013 - 2024 (USD Million)
  • TABLE 19: Japan home infusion therapy market, by application, 2013 - 2024 (USD Million)
  • TABLE 20: China home infusion therapy market, by product, 2013 - 2024 (USD Million)
  • TABLE 21: China home infusion therapy market, by application, 2013 - 2024 (USD Million)
  • TABLE 22: Latin America home infusion therapy market, by product, 2013 - 2024 (USD Million)
  • TABLE 23: Latin America home infusion therapy market, by application, 2013 - 2024 (USD Million)
  • TABLE 24: Brazil home infusion therapy market, by product, 2013 - 2024 (USD Million)
  • TABLE 25: Brazil home infusion therapy market, by application, 2013 - 2024 (USD Million)
  • TABLE 26: Mexico home infusion therapy market, by product, 2013 - 2024 (USD Million)
  • TABLE 27: Mexico home infusion therapy market, by application, 2013 - 2024 (USD Million)
  • TABLE 28: MEA home infusion therapy market, by product, 2013 - 2024 (USD Million)
  • TABLE 29: Middle East and Africa home infusion therapy market, by application, 2013 - 2024 (USD Million)
  • TAsBLE 3: South Africa home infusion therapy market, by product, 2013 - 2024 (USD Million)
  • TABLE 31: South Africa home infusion therapy market, by application, 2013 - 2024 (USD Million)

List of Figures

  • FIG. 1: Market research process
  • FIG. 2: Information procurement
  • FIG. 3: Market summary
  • FIG. 4: Home Infusion Therapy: Market Segmentation
  • FIG. 5: Home infusion therapy market revenue, (USD Million), 2013-2024
  • FIG. 6: Home Infusion: Market Dynamics
  • FIG. 7: Key Opportunities Prioritized
  • FIG. 8: Home infusion therapy Porter's analysis
  • FIG. 9: Home infusion therapy - PESTEL analysis
  • FIG. 10: Global home infusion therapy market share, by product, 2015 & 2024
  • FIG. 11: Infusion pumps market, 2013 - 2024 (USD Million)
  • FIG. 12: Intravenous sets market, 2013 - 2024 (USD Million)
  • FIG. 13: IV cannulas market, 2013 - 2024 (USD Million)
  • FIG. 14: Needleless connectors market, 2013 - 2024 (USD Million)
  • FIG. 15: Global home infusion therapy market share, by application, 2015 & 2024
  • FIG. 16: Anti-Infective market, 2013 - 2024 (USD Million)
  • FIG. 17: Endocrinology market, 2013 - 2024 (USD Million)
  • FIG. 18: Hydration therapy market, 2013 - 2024 (USD Million)
  • FIG. 19: Chemotherapy market, 2013 - 2024 (USD Million)
  • FIG. 20: Enteral nutrition market, 2013 - 2024 (USD Million)
  • FIG. 21: Parenteral nutrition market, 2013 - 2024 (USD Million)
  • FIG. 22: Specialty pharmaceuticals market, 2013 - 2024 (USD Million)
  • FIG. 23: Others market, 2013 - 2024 (USD Million)
  • FIG. 24: Home infusion therapy market share, by region, 2015 & 2024
  • FIG. 25: North America home infusion therapy market, by application, 2013 - 2024 (USD Million)
  • FIG. 26: U.S. home infusion therapy market, by application, 2013 - 2024 (USD Million)
  • FIG. 27: Canada home infusion therapy market, by application, 2013 - 2024 (USD Million)
  • FIG. 28: Europe home infusion therapy market, by application, 2013 - 2024 (USD Million)
  • FIG. 29: Germany home infusion therapy market, 2013 - 2024 (USD Million)
  • FIG. 30: UK home infusion therapy market,2013 - 2024 (USD Million)
  • FIG. 31: Asia Pacific home infusion therapy market,,2013 - 2024 (USD Million)
  • FIG. 32: Japan home infusion therapy market, 2013 - 2024 (USD Million)
  • FIG. 33: China home infusion therapy market, by application, 2013 - 2024 (USD Million)
  • FIG. 34: Latin America home infusion therapy market, by application, 2013 - 2024 (USD Million)
  • FIG. 35: Brazil home infusion therapy market, by application, 2013 - 2024 (USD Million)
  • FIG. 36: Mexico home infusion therapy market, by application, 2013 - 2024 (USD Million)
  • FIG. 37: Middle East and Africa home infusion therapy market, by application, 2013 - 2024 (USD Million)
  • FIG. 38: South Africa home infusion therapy market, by application, 2013 - 2024 (USD Million)
Back to Top